Search Results - "Jison ML"

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Authors: Ogbogu PU Roufosse F Akuthota P et al.

Corporate Authors: Ogbogu PU Roufosse F Akuthota P et al.

Source: Nature medicine [Nat Med] 2026 Jun; Vol. 32 (6), pp. 2319.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process

Echocardiographic characterization and markers of cardiovascular risk in adults with sickle cell disease in a Colombian tertiary referral centre: A cross-sectional study.

Authors: Arrieta-Mendoza, Martin E. Betancourt, Juan R. Ayala-Zapata, Sebastián et al.

Source: PLoS ONE. 6/16/2026, Vol. 21 Issue 6, p1-12. 12p.

Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Authors: Ogbogu PU Roufosse F Akuthota P et al.

Corporate Authors: Ogbogu PU Roufosse F Akuthota P et al.

Source: Nature medicine [Nat Med] 2026 Jun; Vol. 32 (6), pp. 2017-2025. Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Elevated tricuspid regurgitation velocity in adults with sickle cell disease and HbAA controls in Kinshasa, Democratic Republic of the Congo: a comparative cross-sectional study.

Authors: Engole YM Makanzu B Mvunzi TS et al.

Source: Annals of hematology [Ann Hematol] 2026 Mar 20; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 20.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

The pattern of lung function tests in children with sickle cell disease: A case-control study.

Authors: Kannan, Abinaya Sarnaik, Gaurav Agarwal, Nikita et al.

Source: PLoS ONE. 7/28/2025, Vol. 20 Issue 7, p1-10. 10p.

Global prevalence of elevated estimated pulmonary artery systolic pressure in clinically stable children and adults with sickle cell disease: A systematic review and meta-analysis.

Authors: Ghazaiean, Mobin Darvishi-Khezri, Hadi Najafi, Behnam et al.

Source: PLoS ONE. 2/13/2025, Vol. 20 Issue 2, p1-31. 31p.

Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease.

Authors: Mekontso Dessap, Armand Dauger, Stephane Khellaf, Mehdi et al.

Source: Annals of Intensive Care. 5/29/2025, Vol. 15 Issue 1, p1-34. 34p.

Cardiovascular Consequences of Sickle Cell Disease.

Authors: Bahashwan, Salem Almuhanna, Rahaf Mohammad Hazza, Maryam Taher Al et al.

Source: Journal of Blood Medicine. May2024, Vol. 15, p207-216. 10p.

Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review.

Authors: Hersi, Kadija Ramani, Gautam V. Law, Jennie Y. et al.

Source: Pulmonary Circulation. Apr2024, Vol. 14 Issue 2, p1-12. 12p.

Variation in pulmonary function tests among children with sickle cell anemia: a systematic review and metaanalysis.

Authors: Taksande, Amar Jameel, Patel Zeeshan Pujari, Divya et al.

Source: Pan African Medical Journal. May-Aug2021, Vol. 39, p1-20. 20p.

Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease.

Authors: Alasbali R Alzahrani M Wilkerson K et al.

Source: Bone marrow transplantation [Bone Marrow Transplant] 2026 Jul; Vol. 61 (7), pp. 847-851. Date of Electronic Publication: 2026 Apr 28.

Publication Type: Journal Article; Multicenter Study; Clinical Trial

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

BCL11A and HBS1L-MYB polymorphisms, in association with hydroxyurea and sex, modulate fetal hemoglobin levels in individuals with sickle cell anemia in the western region of Bahia, Brazil.

Authors: de Magalhães Filho MF Santana ILR da Silva PLP et al.

Source: Molecular biology reports [Mol Biol Rep] 2026 Jun 23; Vol. 53 (1). Date of Electronic Publication: 2026 Jun 23.

Publication Type: Journal Article

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

Assessment of pulmonary hypertension in patients with sickle cell disease.

Authors: Galal, Ahmed Mahmoud Mohamed Baraket, Nadia Yousef Cheikhrouhou, Imen Abdelhamid

Source: Egyptian Journal of Bronchology. 6/20/2025, Vol. 19 Issue 1, p1-9. 9p.

Pulmonary function assessments and clinical correlates in children with sickle cell disease in Cape Town, South Africa.

Authors: Owusu, Sandra Kwarteng Mapani, Muntanga Kampengele Visagie, Ane et al.

Source: Journal of the Pan African Thoracic Society. Jan-Apr2024, Vol. 5 Issue 1, p1-12. 12p.

On the use of telemedicine in the context of COVID-19: legal aspects and a systematic review of technology.

Authors: de Oliveira Andrade, Adriano Soares, Adeilson Barbosa de Andrade Palis, Angélica et al.

Source: Research on Biomedical Engineering. Mar2022, Vol. 38 Issue 1, p209-227. 19p.

The risk of pulmonary hypertension in sickle cell disease in relation to the disease severity.

Authors: Bahashwan, Salem^1,2 (AUTHOR) smbahashwan1@kau.edu.sa

Source: Iraqi Journal of Hematology. Jan-Jun2025, Vol. 14 Issue 1, p123-126. 4p.

A Descriptive Cross-Sectional Study on Evaluation of Relative Hypertension, Renal Function and Coagulation Abnormalities in Patients with Sickle Cell Disease Among Tribal Population of North Kerala.

Authors: Abraham, Reema Miria Nisha T. R.

Source: European Journal of Cardiovascular Medicine. 2024, Vol. 14 Issue 6, p60-65. 6p.

Role of soluble adhesion molecules (ICAM-1 and E-selectin) in children with sickle cell disease and their association with disease severity and complications.

Authors: Mohamed, Alaa S Botrous, Osama Ezzat Elkareem, Rehab M Abd et al.

Source: Comparative Clinical Pathology. Dec2024, Vol. 33 Issue 6, p855-863. 9p.

Altered cardiac reserve is a determinant of exercise intolerance in sickle cell anaemia patients.

Authors: Hammoudi, Nadjib Ceccaldi, Alexandre Haymann, Jean‐Philippe et al.

Source: European Journal of Clinical Investigation. Jan2022, Vol. 52 Issue 1, p1-11. 11p.

Long‐term tolerability of phosphodiesterase‐5 inhibitors in pulmonary hypertension of sickle cell disease.

Authors: Cramer‐Bour, Cassondra Ruhl, Amy Parker Nouraie, Seyed Mehdi et al.

Source: European Journal of Haematology. Jul2021, Vol. 107 Issue 1, p54-62. 9p.